Post

New research · Oncology
Pharmacy (Basel, Switzerland) · 1w
AI / informaticsPharmacy (Basel, Switzerland) · 2026

Automated Processes and Artificial Intelligence in Generating Candidates for Oncology Drug Repurposing: Three-Year Scoping Review of Data.

Antonio Ivanov, Ines Hababa-Ivanova, Savina Elitova … Violeta Getova-Kolarova
Read paper
OncologyAI / informatics

Scoping review found 42 artificial intelligence oncology drug repurposing projects published 2022-2024

Automated Processes and Artificial Intelligence in Generating Candidates for Oncology Drug Repurposing: Three-Year Scoping Review of Data.

Antonio Ivanov … Violeta Getova-Kolarova
Pharmacy (Basel, Switzerland) · 2026
42
Results
42
Number of individual research projects meeting eligibility and analyzed in this review
n = 42 individual
“
Conclusion

While the search was limited to PubMed and open-access English-language publications, we identified a relatively small number of drug-oriented projects, the importance of providing publicly accessible source code to reduce development costs, and the predominant role of academic institutions.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0.861
the combined model's improved ability to correctly diagnose liver cancer
Guideline
50 and 70 years of age
Australians within this age range are eligible for lung cancer screening
Review
80%
experts agreed on most questions about managing second breast cancer events
Guideline
“As more new targeted agents become available and hypomethylating agent-based triplet combinations are used more widely, we fully anticipate that we will, in some years' time, write a fourth guideline on the management of AML in older patients.”
Cohort Study
3.8-fold
Sickle cell disease recipients had 3.8-fold higher odds of DNA Damage Response-mutant clonal hematopoiesis.
Cross-sectional
1.3%
very few hospitals had a dedicated joint heart-and-cancer specialist team, despite broad support
Study
0.02
Average distance error of 0.02 mm between computed and physically measured locations
Cohort Study
65.3%
65.3% carried two copies of the valine version of the CD19 gene